Segregation analysis of diabetic nephropathy in Pima Indians

Diabetes

Volumn 49, Issue 6, 2000, Pages 1049-1056

  Imperatore, Giuseppina ^a   Knowler, William C ^a   Pettitt, David J ^b   Kobes, Sayuko ^a   Bennett, Peter H ^a   Hanson, Robert L ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; FAMILIAL DISEASE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEGREGATION ANALYSIS;

EID: 0034035443     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.1049     Document Type: Article

References (42)

1. U.S. Renal Data System: USRDS 1994 annual data report: incidence and causes of treated renal disease. Am J Kidney Dis 24 (Suppl. 2):S48-S56, 1994
2. Cordonnier D, Bayle F, Benhamou PY, Milongo R, Zaouli P, Maynard C: Future trends of management of renal failure in diabetics. Kidney Int 43 (Suppl. 41):8-13, 1993
3. Raine AEG: Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 36:1099-1104, 1993
4. Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH: Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 35:681-687, 1989
5. Krolewski AS, Warram JH, Christlieb AR, Busik EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
6. Schmitz A, Vaeth M, Mogensen CE: Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 37:1251-1258, 1994
7. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998-1004, 1998
8. Nelson RG, Knowler WC, Pettitt DJ, Hanson RL, Bennett PH: Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 18:182-187, 1995
9. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314:783-788, 1997
10. U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33). Lancet 352:837-853, 1998
11. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
12. Nielsen FS, Rossing P, Gall MA, Skott P, Smidt UM, Parving HH: Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 46:1182-1188, 1997
13. U.K. Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. U.K. Prospective Diabetes Study Group. BMJ 317:703-713, 1998
14. Seaquist ER, Goetz FC, Rich SS, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
15. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal diseases in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
16. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
17. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945, 1996
18. Faronato PP, Maioli M, Tonolo G, Brocco E, Noventa F, Piarulli F, Abaterusso C, Modena F, de Bigontina G, Velussi M, Inchiostro S, Santeusanio F, Bueti A, Nosadini R: Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM: the Italian NIDDM Nephropathy Study Group. Diabetologia 40:816-823, 1997
19. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC, the Pima Diabetes Genes Group: Sib-pair linkage analysis for susceptibility genes for miorovascular complications among Pima Indians with type 2 diabetes. Diabetes 47:821-830, 1998
20. Jarvik PG: Complex segregation analysis: uses and limitations. Am J Hum Genet 63:942-946, 1998
21. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC: Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 32:870-876, 1989
22. Knowler WC, Pettitt DJ, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978
23. Bennett PH, Burch TA, Miller M: Diabetes mellitus in American (Pima) Indians. Lancet ii:825-828, 1971
24. Shevsky MC, Stafford DD: A clinical method for the estimation of protein in urine and other body fluids. Arch Intern Med 32:222-225, 1923
25. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, Bennett PH: Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia 26:127-133, 1984
26. Snedecor GW, Cochran WG: One-way classification: analysis of variance. In Statistical Methods. 6th ed. Snedecor GW, Cochran WG, Eds. Ames, IA, Iowa State University Press, 1967, p. 294-296
27. Case Western Reserve University: SAGE: Statistical Analysis for Genetic Epidemiology, release 2.2. Cleveland, OH, Department of Epidemiology and Biostatistics, Case Western Reserve University, 1994
28. Bonney GE: Regressive logistic models for familial disease and other binary traits. Biometrics 42:611-625, 1986
29. MacLean CJ, Morton NE, Lew R: Analysis of family resemblance. IV. Operational characteristics of segregation analysis. Am J Hum Genet 27:365-384, 1975
30. Elston RG: Segregation analysis. Adv Hum Genet 11:63-120, 1981
31. Elston RC, George VT: Age of onset, age at examination and other covariates in the analysis of family data. Genet Epidemiol 6:217-220, 1989
32. Akaike H: Information theory and an extension of the maximum likelihood principle. In 2nd International Symposium of Information Theory. Budapest, Akademia Kaido, 1973, p. 267-281
33. Terwilliger JD, Ott J: Advanced application of affection status I: incomplete penetrance revisited. In Handbook of Human Genetic Linkage. Terwilliger JD, Ott J, Eds. Baltimore, MD, Johns Hopkins University Press, 1994, p. 65-72
34. Lalouel JM, Morton NE: Complex segregation analysis with pointers. Hum Hered 31:312-321, 1981
35. Knowler WC, Bennett PH, Bottazzo GF, Doniach D: Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia 17:161-164, 1979
36. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM, Bennett PH: Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31:730-736, 1988
37. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC, the Pima Diabetes Genes Group: Segregation and linkage analyses of diabetic nephropathy in Pima Indians (Abstract). Am J Hum Genet 61 (Suppl. 1):A280, 1997
38. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC: An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130-1138, 1998
39. Fogarty DG, Rich SS, Wantman M, Warram JH, Krolewski AS: Albumin excretion in families with NIDDM is strongly influenced by a major gene: results of a segregation analysis. Diabetes 47 (Suppl. 1):A12, 1998
40. Lewis EJ, Hunsisker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: the Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
41. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 128:982-988, 1998
42. Vieland VJ, Hodge SE, Greenberg DA: Adequacy of single-locus approximations for linkage analyses of oligogenic traits. Genet Epidemiol 9:45-59, 1992